465
Views
0
CrossRef citations to date
0
Altmetric
Review

Integrated Continuous Manufacturing in Pharmaceutical Industry: Current Evolutionary Steps Toward Revolutionary Future

, , , , , , & show all
Pages 139-161 | Received 27 Apr 2019, Accepted 28 May 2019, Published online: 29 Jul 2019

References

  • Gutmann B , CantilloD, KappeCO. Continuous-Flow technology—A tool for the safe manufacturing of active pharmaceutical ingredients. Angew. Chem. Int. Ed. Engl.54(23), 6688–6728 (2015).
  • US FDA . CFR- Code of Federal regualtion Title 21 (2018). www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm
  • Lee SL , O'connorTF, YangXet al. Modernizing pharmaceutical manufacturing: from batch to continuous production. J. Pharm. Innov.10, 191–199 (2015).
  • Ierapetritou M , MuzzioF, ReklaitisG. Perspectives on the continuous manufacturing of powder-based pharmaceutical processes. AIChE J.62(6), 1846–1862 (2016).
  • Getz KA , KaitinKI. Open innovation: The new face of pharmaceutical research and development. Exp. Rev. Clin. Pharm.5(5), 481–483 (2012).
  • U.S. Food and Drug Adminstration (Fda) . Q7 Good manufacturing practice guidance for active pharmaceutical ingredients (2018). www.fda.gov/regulatory-information/search-fda-guidance-documents/q7-good-manufacturing-practice-guidance-active-pharmaceutical-ingredients-guidance-industry
  • Mascia S , HeiderPL, ZhangHet al. End-to-end continuous manufacturing of pharmaceuticals: integrated synthesis, purification and final dosage formation. Angew. Chem. Int. Ed. Engl.52(47), 12359–12363 (2013).
  • Rathore AS , AgarwalH, SharmaAK, PathakM, MuthukumarS. Continuous processing for production of biopharmaceuticals. Prep. Biochem. Biotechnol.45(8), 836–849 (2015).
  • Aksu B , DeBeer T, FolestadSet al. Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT). Eur. J. Pharm. Sci.47(2), 402–405 (2012).
  • Page T , DubinaH, FillipiGet al. Equipment and analytical companies meeting continuous challenges. May 20–21, 2014 Continuous Manufacturing Symposium. J. Pharm. Sci.104(3), 821–831 (2015).
  • Page TG . US20110208436A1 (2011).
  • Allison G , CainYT, CooneyCet al. Regulatory and quality considerations for continuous manufacturing May 20–21, 2014 Continuous Manufacturing Symposium. J. Pharm. Sci.104(3), 803–812 (2015).
  • Chatterjee S . FDA perspective on continuous manufacturing. Presented at: IFPAC Annual Meeting, Baltimore, MD, USA, 22–25 January 2012.
  • Leuenberger H . New trends in the production of pharmaceutical granules: batch versus continuous processing. Eur. J. Pharm. Biopharm.52(3), 289–296 (2001).
  • Poechlauer P , ManleyJ, BroxtermanR, GregertsenB, RidemarkM. Continuous processing in the manufacture of active pharmaceutical ingredients and finished dosage forms: an industry perspective. Org. Proc. Res. Dev.16(10), 1586–1590 (2012).
  • Burcham CL , FlorenceAJ, JohnsonMD. Continuous manufacturing in pharmaceutical process development and manufacturing. Annu. Rev. Chem. Biomol. Eng.9, 253–281 (2018).
  • Warikoo V , GodawatR, BrowerKet al. Integrated continuous production of recombinant therapeutic proteins. Biotechnol. Bioeng.109(12), 3018–3029 (2012).
  • Pollock J , CoffmanJ, HoSV, FaridSS. Integrated continuous bioprocessing: economic, operational, and environmental feasibility for clinical and commercial antibody manufacture. Biotechnol. Prog.33(4), 854–866 (2017).
  • Byrn S , FutranM, ThomasHet al. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium. J. Pharm. Sci.104(3), 792–802 (2015).
  • International Organization for Standardization (ISO) . ISO 9000:2015. 20 March 2019 (2015). www.iso.org/standard/45481.html
  • Myerson AS , KrummeM, NasrM, ThomasH, BraatzRD. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium. J. Pharm. Sci.104(3), 832–839 (2015).
  • May SA . Flow chemistry, continuous processing, and continuous manufacturing: a pharmaceutical perspective. J. Flow Chem.7(3), 137–145 (2017).
  • Matsunami K , NagatoT, HasegawaK, SugiyamaH. A large-scale experimental comparison of batch and continuous technologies in pharmaceutical tablet manufacturing using ethenzamide. Int. J. Pharm.559, 210–219 (2019).
  • Zomer S , ZhangJ, TalwarS, ChattorajS, HewittC. Multivariate monitoring for the industrialisation of a continuous wet granulation tableting process. Int. J. Pharm.547(1–2), 506–519 (2018).
  • Papadakis E , WoodleyJM, GaniR. Chapter 24 - Perspective on PSE in pharmaceutical process development and innovation. In: Computer Aided Chemical Engineering. SinghR, YuanZ ( Eds). Elsevier, Cambridge, MA, USA, 597–656 (2018).
  • Alam MA , ShiZ, DrennenJK3rd, AndersonCA. In-line monitoring and optimization of powder flow in a simulated continuous process using transmission near infrared spectroscopy. Int. J. Pharm.526(1–2), 199–208 (2017).
  • Santos B , CarmoF, SchlindweinWet al. Pharmaceutical excipients properties and screw feeder performance in continuous processing lines: a Quality by Design (QbD) approach. Drug Dev. Ind. Pharm.44(12), 2089–2097 (2018).
  • Van Snick B , DhondtJ, PandelaereKet al. A multivariate raw material property database to facilitate drug product development and enable in silico design of pharmaceutical dry powder processes. Int. J. Pharm.549(1–2), 415–435 (2018).
  • Yu LX . Pharmaceutical quality by design: product and process development, understanding, and control. Pharm. Res.25(4), 781–791 (2008).
  • Hubert C , LebrunP, HouariS, ZiemonsE, RozetE, HubertP. Improvement of a stability-indicating method by Quality-by-Design versus Quality-by-Testing: a case of a learning process. J. Pharm. Biomed. Anal.88, 401–409 (2014).
  • Su Q , GaneshS, MorenoMet al. A perspective on Quality-by-Control (QbC) in pharmaceutical continuous manufacturing. Comp. Chem. Eng.125, 216–231 (2019).
  • Rathore AS , WinkleH. Quality by design for biopharmaceuticals. Nat. Biotech.27(1), 26 (2009).
  • Yu LX , AmidonG, KhanMAet al. Understanding pharmaceutical quality by design. AAPS J.16(4), 771–783 (2014).
  • Grymonpre W , BostijnN, HerckSVet al. Downstream processing from hot-melt extrusion towards tablets: a quality by design approach. Int. J. Pharm.531(1), 235–245 (2017).
  • Lakio S , ErvastiT, TajarobiPet al. Provoking an end-to-end continuous direct compression line with raw materials prone to segregation. Eur. J. Pharm. Sci.109, 514–524 (2017).
  • Schlindwein W , BezerraM, AlmeidaJ, BerghausA, OwenM, MuirheadG. In-Line UV-Vis Spectroscopy as a Fast-Working Process Analytical Technology (PAT) during Early Phase Product Development Using Hot Melt Extrusion (HME). Pharmaceutics10(4), 1–25 (2018).
  • Srai JS , BadmanC, KrummeM, FutranM, JohnstonC. Future supply chains enabled by continuous processing–opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium. J. Pharm. Sci.104(3), 840–849 (2015).
  • Tomba E , DeMartin M, FaccoPet al. General procedure to aid the development of continuous pharmaceutical processes using multivariate statistical modeling – an industrial case study. Int. J. Pharm.444(1–2), 25–39 (2013).
  • Silva AF , SarragucaMC, FonteyneMet al. Multivariate statistical process control of a continuous pharmaceutical twin-screw granulation and fluid bed drying process. Int. J. Pharm.528(1–2), 242–252 (2017).
  • Stauffer F , VanhoorneV, PilcerG, ChavezPF, VervaetC, DeBeer T. Managing API raw material variability during continuous twin-screw wet granulation. Int. J. Pharm.561, 265–273 (2019).
  • Rogers A , HashemiA, IerapetritouM. Modeling of particulate processes for the continuous manufacture of solid-based pharmaceutical dosage forms. Processes1(2), 67–127 (2013).
  • Toson P , SiegmannE, TrogrlicMet al. Detailed modeling and process design of an advanced continuous powder mixer. Int. J. Pharm.552(1), 288–300 (2018).
  • Persson LC , PorterCJH, CharmanWN, BergströmCaS. Computational prediction of drug solubility in lipid based formulation excipients. Pharmaceutical Res.30(12), 3225–3237 (2013).
  • O'connell JP , GaniR, MathiasPM, MaurerG, OlsonJD, CraftsPA. Thermodynamic property modeling for chemical process and product engineering: Some perspectives. Ind. Eng. Chem. Res.48(10), 4619–4637 (2009).
  • Boukouvala F , ChaudhuryA, SenMet al. Computer-aided flowsheet simulation of a pharmaceutical tablet manufacturing process incorporating wet granulation. J. Pharm. Innov.8(1), 11–27 (2013).
  • Boeckx J , PageTG, WaldronMS. WO2010128359A1 (2017).
  • Escotet-Espinoza MS , VadodariaS, SinghR, MuzzioFJ, IerapetritouMG. Modeling the effects of material properties on tablet compaction: A building block for controlling both batch and continuous pharmaceutical manufacturing processes. Int. J. Pharm.543(1), 274–287 (2018).
  • García-Muñoz S , ButterbaughA, LeavesleyI, ManleyLF, SladeD, BerminghamS. A flowsheet model for the development of a continuous process for pharmaceutical tablets: an industrial perspective. AIChE J.64(2), 511–525 (2018).
  • Wang Z , Escotet-EspinozaMS, IerapetritouM. Process analysis and optimization of continuous pharmaceutical manufacturing using flowsheet models. Comput. Chem. Eng.107, 77–91 (2017).
  • Fernandez EG , CorderoS, BenitezMet al. Rapid development and optimization of tablet manufacturing using statistical tools. AAPS PharmSciTech9(2), 620–627 (2008).
  • Collins LM , DziakJJ, LiR. Design of experiments with multiple independent variables: a resource management perspective on complete and reduced factorial designs. Psych. Met.14(3), 202–224 (2009).
  • Nasr MM , KrummeM, MatsudaYet al. Regulatory perspectives on continuous pharmaceutical manufacturing: moving from theory to practice: September 26-27, 2016, international symposium on the continuous manufacturing of pharmaceuticals. J. Pharm. Sci.106(11), 3199–3206 (2017).
  • Gao Y , IerapetritouM, MuzzioF. Periodic section modeling of convective continuous powder mixing processes. AIChE J.58(1), 69–78 (2012).
  • Kruisz J , RehrlJ, SacherS, AignerI, HornM, KhinastJG. RTD modeling of a continuous dry granulation process for process control and materials diversion. Int. J. Pharm.528(1–2), 334–344 (2017).
  • Martinetz MC , KarttunenAP, SacherSet al. RTD-based material tracking in a fully-continuous dry granulation tableting line. Int. J. Pharm.547(1–2), 469–479 (2018).
  • Laske S , PaudelA, ScheibelhoferO, AuthorT. A review of PAT strategies in secondary solid oral dosage manufacturing of small molecules. J. Pharm. Sci.106(3), 667–712 (2017).
  • Maniruzzaman M , DouroumisD. Continuous manufacturing and process analytical tools. Int. J. Pharm.496(1), 1–2 (2015).
  • International Conference on Harmonisation (Ich) . Guidance for industry: Q8 (R2) (pharmaceutical development). Center for Drug Evaluation and Research (2009). www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf
  • (Fda) FDA . Guidance for industry, PAT-A framework for innovative pharmaceutical development, manufacturing and quality assurance (2004). www.fda.gov/media/71012/download
  • Esmonde-White KA , CuellarM, UerpmannC, LenainB, LewisIR. Raman spectroscopy as a process analytical technology for pharmaceutical manufacturing and bioprocessing. Anal. Bioanal. Chem.409(3), 637–649 (2017).
  • Ganesh S , TroscinskiR, SchmallN, LimJ, NagyZ, ReklaitisG. Application of x-ray sensors for in-line and noninvasive monitoring of mass flow rate in continuous tablet manufacturing. J. Pharm. Sci.106(12), 3591–3603 (2017).
  • Nagy B , FarkasA, MagyarK, DemuthB, NagyZK, MarosiG. Spectroscopic characterization of tablet properties in a continuous powder blending and tableting process. Eur. J. Pharm. Sci.123, 10–19 (2018).
  • Rathore AS , WoodR, SharmaA, DermawanS. Case study and application of process analytical technology (PAT) towards bioprocessing: II. Use of ultra-performance liquid chromatography (UPLC) for making real-time pooling decisions for process chromatography. Biotechnol. Bioeng.101(6), 1366–1374 (2008).
  • Maniruzzaman M , NairA, RenaultMet al. Continuous twin-screw granulation for enhancing the dissolution of poorly water soluble drug. Int. J. Pharm.496(1), 52–62 (2015).
  • Xu X , VallabhCKP, HoagSW, DaveVS, CetinkayaC. Early detection of capping risk in pharmaceutical compacts. Int. J. Pharm.553(1-2), 338–348 (2018).
  • Maniruzzaman M , NokhodchiA. Continuous manufacturing via hot-melt extrusion and scale up: regulatory matters. Drug Discov. Today22(2), 340–351 (2017).
  • Reich G . Near-infrared spectroscopy and imaging: basic principles and pharmaceutical applications. Adv. Drug Deliv. Rev.57(8), 1109–1143 (2005).
  • Blanco M , BautistaM, AlcalàM. API determination by NIR spectroscopy across pharmaceutical production process. AAPS PharmSciTech9(4), 1130–1135 (2008).
  • Vo AQ , HeH, ZhangJ, MartinS, ChenR, RepkaMA. Application of FT-NIR analysis for in-line and real-time monitoring of pharmaceutical hot melt extrusion: a technical note. AAPS PharmSciTech19(8), 3425–3429 (2018).
  • Acevedo D , MuliadiA, GiridharA, LitsterJD, RomanachRJ. Evaluation of three approaches for real-time monitoring of roller compaction with near-infrared spectroscopy. AAPS PharmSciTech13(3), 1005–1012 (2012).
  • Crowley ME , HegartyA, McauliffeMaPet al. Near-infrared monitoring of roller compacted ribbon density: investigating sources of variation contributing to noisy spectral data. Eur. J. Pharm. Sci.102, 103–114 (2017).
  • Tezyk M , MilanowskiB, ErnstA, LulekJ. Recent progress in continuous and semi-continuous processing of solid oral dosage forms: a review. Drug Dev. Ind. Pharm.42(8), 1195–1214 (2016).
  • Riolo D , PiazzaA, CottiniCet al. Raman spectroscopy as a PAT for pharmaceutical blending: advantages and disadvantages. J. Pharm. Biomed. Anal.149, 329–334 (2018).
  • Acevedo D , YangX, MohammadAet al. Raman spectroscopy for monitoring the continuous crystallization of carbamazepine. Org. Process Res. Dev.22(2), 156–165 (2018).
  • Abu-Absi NR , KentyBM, CuellarMEet al. Real time monitoring of multiple parameters in mammalian cell culture bioreactors using an in-line Raman spectroscopy probe. Biotechnol. Bioeng.108(5), 1215–1221 (2011).
  • Chavan RB , ThipparaboinaR, YadavB, ShastriNR. Continuous manufacturing of co-crystals: challenges and prospects. Drug Deliv. Transl. Res.8(6), 1726–1739 (2018).
  • U.S. Food and Drug Adminstration (Fda) . Quality considerations for continuous manufacturing guidance for industry. Human Drug Information (2019). www.fda.gov/media/121314/download
  • Farias M , CarneiroR. Simultaneous quantification of three polymorphic forms of carbamazepine in the presence of excipients using Raman spectroscopy. Mol.19(9), 14128–14138 (2014).
  • Matthews TE , CoffmanC, KolwyckD, HillD, DickensJE. Enabling robust and rapid raw material identification and release by handheld raman spectroscopy. PDA J. Pharm. Sci. Technol. doi:10.5731/pdajpst.2018.009563 (2019) (Epub ahead of print).
  • Fonteyne M , WickstromH, PeetersEet al. Influence of raw material properties upon critical quality attributes of continuously produced granules and tablets. Eur. J. Pharm. Biopharm.87(2), 252–263 (2014).
  • Escotet-Espinoza MS , VadodariaS, SinghR, MuzzioFJ, IerapetritouMG. Modeling the effects of material properties on tablet compaction: A building block for controlling both batch and continuous pharmaceutical manufacturing processes. Int. J. Pharm.543(1–2), 274–287 (2018).
  • Kushner J , LangdonBA, HillerJI, CarlsonGT. Examining the impact of excipient material property variation on drug product quality attributes: a quality-by-design study for a roller compacted, immediate release tablet. J. Pharm. Sci.100(6), 2222–2239 (2011).
  • Wahl PR , TrefferD, MohrS, RobleggE, KoscherG, KhinastJG. Inline monitoring and a PAT strategy for pharmaceutical hot melt extrusion. Int. J. Pharm.455(1–2), 159–168 (2013).
  • Ooi SM , SarkarS, Van VarenberghG, SchoetersK, HengPW. Continuous processing and the applications of online tools in pharmaceutical product manufacture: developments and examples. Therap. Del.4(4), 463–470 (2013).
  • Shanmugam S . Granulation techniques and technologies: recent progresses. BioImpacts. BI5(1), 55 (2015).
  • Kleinebudde P . Roll compaction/dry granulation: pharmaceutical applications. Eur. J. Pharm. Biopharm.58(2), 317–326 (2004).
  • Herting MG , KleinebuddeP. Studies on the reduction of tensile strength of tablets after roll compaction/dry granulation. Eur. J. Pharm. Biopharm.70(1), 372–379 (2008).
  • Farrenkopf J . Relevant aspects of roller compaction covering the impact of excipients, milling devices, fines and feasibility prediction (2009).
  • Singh R , IerapetritouM, RamachandranR. An engineering study on the enhanced control and operation of continuous manufacturing of pharmaceutical tablets via roller compaction. Int. J. Pharm.438(1), 307–326 (2012).
  • Agrawal R , NaveenY. Pharmaceutical processing: a review on wet granulation technology. Int. J. Pharm. Front. Res.1(1), 65–83 (2011).
  • Vervaet C , RemonJP. Continuous granulation in the pharmaceutical industry. Chem. Eng. Sci.60(14), 3949–3957 (2005).
  • Ghebre-Sellassie I , MollanJr MJ, PathakN, LodayaM, FessehaieM. US6499984B1 (2002).
  • Baronsky-Probst J , MoltgenCV, KesslerW, KesslerRW. Process design and control of a twin screw hot melt extrusion for continuous pharmaceutical tamper-resistant tablet production. Eur. J. Pharm. Sci.87, 14–21 (2016).
  • Nicolaï N , DeLeersnyder F, CopotDet al. Liquid-to-solid ratio control as an advanced process control solution for continuous twin-screw wet granulation. AIChE J.64(7), 2500–2514 (2018).
  • Seem TC , RowsonNA, IngramAet al. Twin screw granulation: a literature review. Powder Technol.276, 89–102 (2015).
  • Maniruzzaman M , NairA, ScoutarisN, BradleyMS, SnowdenMJ, DouroumisD. One-step continuous extrusion process for the manufacturing of solid dispersions. Int. J. Pharm.496(1), 42–51 (2015).
  • Mcclements DJ . Recent progress in hydrogel delivery systems for improving nutraceutical bioavailability. Food Hydrocol.68, 238–245 (2017).
  • Van Hauwermeiren D , VerstraetenM, DoshiPet al. On the modelling of granule size distributions in twin-screw wet granulation: Calibration of a novel compartmental population balance model. Powder Technol.341, 116–125 (2019).
  • Zhang Y , LawY, ChakrabartiS. Physical properties and compact analysis of commonly used direct compression binders. AAPS PharmSciTech4(4), 489–499 (2003).
  • Van Snick B , HolmanJ, CunninghamCet al. Continuous direct compression as manufacturing platform for sustained release tablets. Int. J. Pharm.519(1–2), 390–407 (2017).
  • Jivraj M , MartiniLG, ThomsonCM. An overview of the different excipients useful for the direct compression of tablets. Pharm. Sci. Tech. Today3(2), 58–63 (2000).
  • Chattoraj S , SunCC. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression. J. Pharm. Sci.107(4), 968–974 (2018).
  • Kowalski J , LakshmanJP, SerajuddinATM, TongW, VasanthavadaM. WO2009134848A1 (2011).
  • Simonaho S , KetolainenJ, ErvastiT, ToiviainenM, KorhonenO. Continuous manufacturing of tablets with PROMIS-line — Introduction and case studies from continuous feeding, blending and tableting. Eur. J. Pharm. Sci.90, 38–46 (2016).
  • Ervasti T , SimonahoS, KetolainenJet al. Continuous manufacturing of extended release tablets via powder mixing and direct compression. Int. J. Pharm.495(1), 290–301 (2015).
  • Bostijn N , Van RenterghemJ, DhondtW, VervaetC, DeBeer T. A continuous manufacturing concept for a pharmaceutical oral suspension. Eur. J. Pharm. Sci.123, 576–583 (2018).
  • Walsh G . Biopharmaceuticals and biotechnology medicines: an issue of nomenclature. Eur. J. Pharm. Sci.15(2), 135–138 (2002).
  • Hong MS , SeversonKA, JiangM, LuAE, LoveJC, BraatzRD. Challenges and opportunities in biopharmaceutical manufacturing control. Comp. Chem. Eng.110, 106–114 (2018).
  • Shire SJ . Formulation and manufacturability of biologics. Curr. Opin. Biotech.20(6), 708–714 (2009).
  • Tamizi E , JouybanA. The potential of the capillary electrophoresis techniques for quality control of biopharmaceuticals: a review. Electroph.36(6), 831–858 (2015).
  • Rosa PaJ , AzevedoAM, SommerfeldS, MutterM, BäckerW, Aires-BarrosMR. Continuous purification of antibodies from cell culture supernatant with aqueous two-phase systems: from concept to process. Biotechnol. J.8(3), 352–362 (2013).
  • Boi C . Membrane adsorbers as purification tools for monoclonal antibody purification. J. Chromatogr. B848(1), 19–27 (2007).
  • Konstantinov K , GodawatR, WarikooV, JainS. Integrated continuous manufacturing of therapeutic protein drug substances (2017). https://patents.google.com/patent/US9650412B2/en
  • Ransohoff TC , BisschopsMaT. WO2012078677A3 (2012).
  • Baumann M , BaxendaleIR. The synthesis of active pharmaceutical ingredients (APIs) using continuous flow chemistry. Beilstein. J. Org. Chem.11, 1194–1219 (2015).
  • Adamo A , BeingessnerR, BehnamMet al. On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system. Science352(6281), 61–67 (2016).
  • Crowell E , LuAE, LoveKRet al. On-demand manufacturing of clinical-quality biopharmaceuticals. Nat. Biotech.36, 988–995 (2018).
  • Gross TD , ChouS, BonnevilleDet al. Chemical development of NBI-75043. Use of a flow reactor to circumvent a batch-limited metal− Halogen exchange reaction. Org. Proc. Res. Dev.12(5), 929–939 (2008).
  • Therre J , OostC. WO2001016237A2 (2001).
  • Vanarase AU , OsorioJG, MuzzioFJ. Effects of powder flow properties and shear environment on the performance of continuous mixing of pharmaceutical powders. Powder Technol.246, 63–72 (2013).
  • Tazzia CL , VillalobosMA, HarrisMA. Process for continuous production of epoxy resins (2012). https://patents.google.com/patent/US8242234B2/en
  • Born SC , DittrichJV, TakizaBT, MasciaS. Continuous drum dryer and methods of use thereof (2017). https://patents.google.com/patent/WO2017136765A1/en
  • Patil H , KulkarniV, MajumdarS, RepkaMA. Continuous manufacturing of solid lipid nanoparticles by hot melt extrusion. Int. J. Pharm.471(1), 153–156 (2014).
  • Hou D , XieC, HuangK, ZhuC. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials24(10), 1781–1785 (2003).
  • Maherani B , Arab-TehranyE, RMozafari M, GaianiC, LinderM. Liposomes: a review of manufacturing techniques and targeting strategies. Curr. Nanosci.7(3), 436–452 (2011).
  • Dimov N , KastnerE, HussainM, PerrieY, SzitaN. Formation and purification of tailored liposomes for drug delivery using a module-based micro continuous-flow system. Sci. Rep.7(1), 12045 (2017).
  • Wagner A , Vorauer-UhlK, KatingerH. Liposomes produced in a pilot scale: production, purification and efficiency aspects. Eur. J. Pharm. Biopharm.54(2), 213–219 (2002).
  • Ruysschaert T , MarqueA, DuteyratJ, LesieurS, WinterhalterM, FournierD. Liposome retention in size exclusion chromatography. BMC Biotech.5(1), 11 (2005).
  • Costa A , BurgessDJ. Systems and methods for continuous manufacturing of liposomal drug formulations (2019). https://patents.google.com/patent/US20190029959A1/en
  • Aboofazeli R . Nanometric-scaled emulsions (nanoemulsions). Iran. J. Pharm. Res.9(4), 325–326 (2010).
  • Sah E , SahH. Recent trends in preparation of poly (lactide-co-glycolide) nanoparticles by mixing polymeric organic solution with antisolvent. J. Nanomat.16(1), 61 (2015).
  • Choi G , KakumanuS, SchmitzL, RobinsonGL, BeckettCD, LaugharnJr JA. Continuous manufacturing of carboxyamidotriazole-encapsulated nanoemulsions using adaptive focused acoustics: potential green technology for the pharmaceutical industry. J. Biomed. Eng. Informatics. 1(19), 20 (2016).
  • Jeevanandam J , BarhoumA, ChanYS, DufresneA, DanquahMK. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein. J. Nanotechnol.9, 1050–1074 (2018).
  • Fonseca T , DuarteI, TemtemM, VicenteJ. Continuous production of particles. WO2016156841A1 (2018). https://patents.google.com/patent/WO2016156841A1/en?oq=WO2016156841A1
  • Gottlieb S . FDA budget matters: investing in advanced domestic manufacturing. FDA Blog (2018).
  • U.S. Food and Drug Adminstration (Fda) . FDA supports critical research to spur innovation for continuous manufacturing technology to support and advance drug and biologics development (2018). www.fda.gov/news-events/fda-brief/fda-supports-critical-research-spur-innovation-continuous-manufacturing-technology-support-and
  • Jolliffe HG , GerogiorgisDI. Plantwide design and economic evaluation of two Continuous Pharmaceutical Manufacturing (CPM) cases: Ibuprofen and artemisinin. Comp. Chem. Eng.91, 269–288 (2016).
  • Transparency Market Research . Pharmaceutical continuous manufacturing market (application - active pharmaceutical ingredient, biologics, and dry powders; end users - pharmaceutical companies and contract manufacturing organization) global industry analysis, size, share, growth, trends, and forecast 2017 - 2025 (2017). www.transparencymarketresearch.com/pharmaceutical-continuous-manufacturing-technology-market.html
  • Global pharmaceutical continuous manufacturing market to surpass USD 3406.0 million by 2024 www.globenewswire.com/news-release/2018/09/06/1566507/0/en/Global-Pharmaceutical-Continuous-Manufacturing-Market-to-Surpass-USD-3406-0-Million-By-2024-Zion-Market-Research.html
  • Wallack T . Novartis to give MIT $65m to find new way to produce drugs. The Boston Globe (2007). http://archive.boston.com/business/articles/2007/09/28/novartis_to_give_mit_65m_to_find_new_way_to_produce_drugs/
  • Matsuda Y . Global Regulatory Landscape. AAPS PharmSciTech20(1), 2 (2019).
  • Urquhart L . Regulatory watch: FDA new drug approvals in Q1 2018. Nat. Rev. Drug Discov.17(5), 309 (2018).
  • Diprospero D . Continuous OSD manufacturing - A product & patient perspective. Int. Soc. Pharm. Engl. (2018). https://ispe.org/pharmaceutical-engineering/ispeak/continuous-osd-manufacturing-product-patient-perspective
  • Macdonald G . Janssen working on other continuous processes post US FDA OK for Prezista. In: PharmaTech (2016).
  • Kim E . Abemaciclib: first global approval. Drugs77(18), 2063–2070 (2017).
  • Schneider EK , Reyes-OrtegaF, WilsonJWet al. Development of HPLC and LC–MS/MS methods for the analysis of ivacaftor, its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with ORKAMBI or KALYDECO. J. Chromatogr. B1038, 57–62 (2016).
  • Vertex Pharmaceuticals Company . Vertex reports full-year and fourth-quarter 2017 financial results. (2018). https://investors.vrtx.com/news-releases/news-release-details/vertex-reports-full-year-and-fourth-quarter-2017-financial
  • Vertex Pharmaceuticals Company . Vertex reports full-year and fourth-quarter 2018 financial results. (2019). https://investors.vrtx.com/news-releases/news-release-details/vertex-reports-full-year-and-fourth-quarter-2018-financial
  • Lohr L . Abemaciclib (verzenio™). Onc. Times40(6), 12 (2018).
  • Eli Lilly Q4: Looking at low verzenio sales and the loxo oncology acquisition https://seekingalpha.com/article/4239475-eli-lilly-q4-looking-low-verzenio-sales-loxo-oncology-acquisition
  • Matsunami K , MiyanoT, AraiH, NakagawaH, HiraoM, SugiyamaH. Decision support method for the choice between batch and continuous technologies in solid drug product manufacturing. Ind. Eng. Chem. Res.57(30), 9798–9809 (2018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.